Literature DB >> 25261607

Myocardial matrix metalloproteinase-2: inside out and upside down.

Ashley DeCoux1, Merry L Lindsey2, Francisco Villarreal3, Ricardo A Garcia4, Richard Schulz5.   

Abstract

Since their inaugural discovery in the early 1960s, matrix metalloproteinases (MMPs) have been shown to mediate multiple physiological and pathological processes. In addition to their canonical function in extracellular matrix (ECM) remodeling, research in the last decade has highlighted new MMP functions, including proteolysis of novel substrates beyond ECM proteins, MMP localization to subcellular organelles, and proteolysis of susceptible intracellular proteins in those subcellular compartments. This review will provide a comparison of the extracellular and intracellular roles of MMPs, illustrating that MMPs are far more interesting than the one-dimensional view originally taken. We focus on the roles of MMP-2 in cardiac injury and repair, as this is one of the most studied MMPs in the cardiovascular field. We will highlight how understanding all dimensions, such as localization of activity and timing of interventions, will increase the translational potential of research findings. Building upon old ideas and turning them inside out and upside down will help us to better understand how to move the MMP field forward.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Doxycycline; Heart failure; MMP-2; Myocardial ischemia and infarction; TIPTOP

Mesh:

Substances:

Year:  2014        PMID: 25261607      PMCID: PMC4312173          DOI: 10.1016/j.yjmcc.2014.09.016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  114 in total

1.  Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.

Authors:  T Etoh; C Joffs; A M Deschamps; J Davis; K Dowdy; J Hendrick; S Baicu; R Mukherjee; M Manhaini; F G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

Review 3.  Pharmacologic therapeutics for cardiac reperfusion injury.

Authors:  Eric R Gross; Garrett J Gross
Journal:  Expert Opin Emerg Drugs       Date:  2007-09       Impact factor: 4.191

4.  Matrix metalloproteinases degrade myelin basic protein.

Authors:  S Chandler; R Coates; A Gearing; J Lury; G Wells; E Bone
Journal:  Neurosci Lett       Date:  1995-12-15       Impact factor: 3.046

5.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

6.  Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.

Authors:  Miranda M Sung; Christina G Schulz; Wenjie Wang; Grzegorz Sawicki; Norma L Bautista-López; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2007-07-31       Impact factor: 5.000

7.  Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.

Authors:  Jennifer A Kwan; Costas J Schulze; Wenjie Wang; Hernando Leon; Meltem Sariahmetoglu; Miranda Sung; Jolanta Sawicka; David E Sims; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2004-02-06       Impact factor: 5.191

8.  Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion.

Authors:  Eric R Gross; Anna K Hsu; Garrett J Gross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-25       Impact factor: 4.733

9.  MMP-2 is localized to the mitochondria-associated membrane of the heart.

Authors:  Bryan G Hughes; Xiaohu Fan; Woo Jung Cho; Richard Schulz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-27       Impact factor: 4.733

10.  Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart.

Authors:  Ricardo A Garcia; Katrina V Go; Francisco J Villarreal
Journal:  Mol Cell Biochem       Date:  2006-12-06       Impact factor: 3.842

View more
  38 in total

Review 1.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

2.  Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.

Authors:  Zhaobo Fan; Minghuan Fu; Zhaobin Xu; Bo Zhang; Zhihong Li; Haichang Li; Xinyu Zhou; Xuanyou Liu; Yunyan Duan; Pei-Hui Lin; Pu Duann; Xiaoyun Xie; Jianjie Ma; Zhenguo Liu; Jianjun Guan
Journal:  Biomacromolecules       Date:  2017-08-07       Impact factor: 6.988

Review 3.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

4.  Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.

Authors:  Kathleen C Woulfe; Austine K Siomos; Hieu Nguyen; Megan SooHoo; Csaba Galambos; Brian L Stauffer; Carmen Sucharov; Shelley Miyamoto
Journal:  J Card Fail       Date:  2016-11-24       Impact factor: 5.712

5.  α1A-Subtype adrenergic agonist therapy for the failing right ventricle.

Authors:  Patrick M Cowley; Guanying Wang; Sunil Joshi; Philip M Swigart; David H Lovett; Paul C Simpson; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

6.  Cardiac fibroblast activation during myocardial infarction wound healing: Fibroblast polarization after MI.

Authors:  Michael J Daseke; Mavis A A Tenkorang; Upendra Chalise; Shelby R Konfrst; Merry L Lindsey
Journal:  Matrix Biol       Date:  2020-05-21       Impact factor: 11.583

7.  Functional annotation of differentially expressed fetal cardiac microRNA targets: implication for microRNA-based cardiovascular therapeutics.

Authors:  Sharad Saxena; Anubhuti Gupta; Vaibhav Shukla; Vibha Rani
Journal:  3 Biotech       Date:  2018-11-21       Impact factor: 2.406

8.  TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.

Authors:  Pavel Zhabyeyev; Subhash K Das; Ratnadeep Basu; Mengcheng Shen; Vaibhav B Patel; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

9.  Volume overload induces autophagic degradation of procollagen in cardiac fibroblasts.

Authors:  Lianwu Fu; Chih-Chang Wei; Pamela C Powell; Wayne E Bradley; James F Collawn; Louis J Dell'Italia
Journal:  J Mol Cell Cardiol       Date:  2015-10-24       Impact factor: 5.000

10.  Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.

Authors:  S-L Puhl; A Kazakov; A Müller; P Fries; D R Wagner; M Böhm; C Maack; Y Devaux
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.